Literature DB >> 18760522

Fetal blood sampling in labour and the decision to delivery interval.

Rajesh Annappa1, David James Campbell, Nigel A B Simpson.   

Abstract

OBJECTIVE: To determine the time interval from decision to result for fetal blood sampling (FBS) and the time from an abnormal pH result to delivery of the neonate. STUDY
DESIGN: A prospective study of 107 consecutive attempts at FBS on 72 out of 1450 patients in labour from 1st April 2006 to 1st August 2006 at St James University Hospital in Leeds, England. Statistical analysis was performed by using nonparametric tests.
RESULTS: 107 attempts at FBS on 72 cases were reviewed. Overall the median time from decision to the result of FBS was 17min (interquartile range: 11-22min). 27% (19/70) of fetuses had abnormal results and the median time from result to delivery was 21min (interquartile range: 16-25min) in these cases. The median time from decision to perform FBS to delivery was 37min in cases where acidaemia was present. Body mass index (BMI) cervical dilatation and grade of operator were the factors which affected median time from decision to the result of FBS.
CONCLUSION: The time from decision to the result of FBS should be considered in the delivery decision-making process in cases complicated by suspected fetal compromise.

Entities:  

Mesh:

Year:  2008        PMID: 18760522     DOI: 10.1016/j.ejogrb.2008.07.002

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

1.  How often is a low Apgar score the result of substandard care during labour?

Authors:  S Berglund; H Pettersson; S Cnattingius; C Grunewald
Journal:  BJOG       Date:  2010-04-20       Impact factor: 6.531

2.  Digital fetal scalp stimulation (dFSS) versus fetal blood sampling (FBS) to assess fetal wellbeing in labour-a multi-centre randomised controlled trial: Fetal Intrapartum Randomised Scalp Stimulation Trial (FIRSST NCT05306756).

Authors:  D J Murphy; Y Shahabuddin; S Yambasu; K O'Donoghue; D Devane; A Cotter; G Gaffney; L A Burke; E J Molloy; F Boland
Journal:  Trials       Date:  2022-10-04       Impact factor: 2.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.